Armlupeg (pegfilgrastim or pegfilgrastim-unne) is a biosimilar to Neulasta (pegfilgrastim) that received FDA approval in November 2025. It's an injection used in adults and children to lower infection risk during certain cancer treatments and improve survival after harmful radiation exposure. The medication comes as a prefilled syringe that's injected under the skin. Common side effects include bone pain and pain in the arms or legs.
Lower the risk of infection in adults and children receiving certain cancer treatments that can lower white blood cell levels (febrile neutropenia)
Increase survival in adults and children exposed to high doses of radiation that severely damage the bone marrow
How Armlupeg (pegfilgrastim) works
Armlupeg (pegfilgrastim) is a granulocyte colony-stimulating factor (G-CSF), a type of leukocyte growth factor. It works like G-CSF, a protein your body naturally makes. G-CSF triggers your bone marrow to make more neutrophils, a type of white blood cell that helps fight infections.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Common Side Effects
Bone pain (31%)
Pain in arms or legs (9%)
Less Common Side Effects
Injection site reactions
Rash
Hives
Armlupeg (pegfilgrastim) serious side effects
Contact your healthcare provider immediately if you experience any of the following.
Spleen rupture: pain in your left upper stomach, pain in your left shoulder
Lung problem: shortness of breath, fever, trouble breathing, fast rate of breathing
Serious allergic reaction: rash, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, sweating
Kidney problems: swelling of your face or ankles, urinating less than usual, blood in your urine or dark colored urine
Capillary leak syndrome: swelling of your stomach, dizziness or feeling faint, trouble breathing, urinating less than usual, tiredness
Blood vessel inflammation: fever, stomach pain, back pain, headache, neck pain, generally feeling unwell
When do Armlupeg (pegfilgrastim) possible side effects begin and end?
The following Armlupeg (pegfilgrastim) side effects have also been reported
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Armlupeg (pegfilgrastim) shouldn't be given within 14 days before or 24 hours after chemotherapy. Getting the medication too close to chemotherapy can affect how well treatment works.
Keep all blood test appointments while receiving Armlupeg (pegfilgrastim). Your care team will check your white blood cell levels to make sure they're in a safe range.
Bone pain is common with Armlupeg (pegfilgrastim). Ask your care team which pain relievers are safe for you before taking anything on your own.
Contact your care team right away if you have pain in the upper left side of your stomach or left shoulder while receiving Armlupeg (pegfilgrastim). This could be a sign of a serious spleen problem.
Store Armlupeg (pegfilgrastim) in the refrigerator, protect it from light, and don't shake it.
Pregnancy and breastfeeding: Talk to your care team before receiving Armlupeg (pegfilgrastim) if you're pregnant, planning to become pregnant, or breastfeeding. There isn't enough information to know for sure whether the medication can harm an unborn or breastfed baby.
Storage: Keep Armlupeg (pegfilgrastim) in the refrigerator and protect it from light. Don't freeze or shake the medication.
How to inject Armlupeg (pegfilgrastim)
If you'll be injecting at home, your care team will show you or your caregiver how to give the shot safely. Follow the Instructions for Use and ask your care team if you have questions.
Take the syringe out of the refrigerator 30 minutes before your injection to let it reach room temperature on its own, leaving the needle cap in place. Throw away syringes stored at room temperature for more than 48 hours (2 days).
You can inject under the skin of your thigh or stomach, at least 2 inches away from your belly button. A caregiver can also give the shot in your upper outer buttocks or the outer area of your upper arm.
To inject, pull the needle cap straight off. Then pinch a fold of clean skin. Insert the needle at a 45° to 90° angle, push the plunger all the way down, then remove the needle and release the plunger so the safety guard covers the needle.
After each use, place the syringe in a sharps container. This helps prevent accidental needlestick injuries.
Risks and warnings for Armlupeg (pegfilgrastim)
Armlupeg (pegfilgrastim) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Spleen rupture
Rarely, Armlupeg (pegfilgrastim) can cause your spleen to become enlarged. In serious cases, the spleen can rupture (break open), which can be life-threatening. Get medical help right away if you have pain in the upper left side of your stomach or in your left shoulder.
Lung problem
Armlupeg (pegfilgrastim) can cause acute respiratory distress syndrome (ARDS), a serious lung condition that makes it hard to breathe and get enough oxygen. Get medical help right away if you develop trouble breathing or shortness of breath, especially if you also have a fever.
Serious allergic reactions
Risk factors: Allergy to Armlupeg (pegfilgrastim) or similar medications | Allergy to latex
Armlupeg (pegfilgrastim) can cause serious allergic reactions that can be life-threatening if not treated. These reactions are more likely after your first dose, but symptoms can return days after the first reaction is treated.
You shouldn't receive Armlupeg (pegfilgrastim) if you've had a serious allergic reaction to it or a similar medication, such as Neupogen (filgrastim). The prefilled syringes also contain latex so tell your prescriber if you have a latex allergy. Get medical help right away if you have trouble breathing, swelling of your face or throat, hives, or severe dizziness.
Sickle cell crisis in people with sickle cell anemia
Risk factors: Sickle cell anemia
In people with sickle cell anemia, Armlupeg (pegfilgrastim) can trigger a serious and sometimes life-threatening sickle cell crisis. Symptoms can include severe pain, trouble breathing, chest pain, fever, or extreme tiredness. If a sickle cell crisis happens, the care team will stop the medication and provide treatment.
Kidney problems
Armlupeg (pegfilgrastim) can rarely cause glomerulonephritis, a condition where the tiny filters in the kidneys become inflamed. Signs can include blood in the urine, dark colored urine, swelling, or urinating less than usual. If this happens, the care team might lower the dose or stop the medication.
Changes in blood cell counts
Armlupeg (pegfilgrastim) can cause your white blood cell count to become too high. Your care team will check your complete blood count (CBC) during treatment to make sure your levels stay in a safe range.
Armlupeg (pegfilgrastim) can also lower your platelet count, which can raise your risk of bruising or bleeding. Tell your care team if you notice unusual bruising, nosebleeds, or bleeding that's hard to stop.
Capillary leak syndrome
Colony-stimulating factor medications like Armlupeg (pegfilgrastim) can rarely cause capillary leak syndrome (CLS). This is a serious condition where fluid leaks out of small blood vessels into nearby tissues. It can cause low blood pressure, swelling, dizziness, or weakness and can be life-threatening without quick treatment. Get medical help right away if these symptoms develop.
Risk of certain cancers
Armlupeg (pegfilgrastim) is a growth factor that mainly helps your body make more white blood cells. But there's a possibility it could also promote the growth of certain cancer cells.
Rarely, people with breast or lung cancer have developed blood cancers or bone marrow problems while receiving Armlupeg (pegfilgrastim) with chemotherapy or radiation. Your care team will monitor your blood tests and might stop the medication if the risks become greater than the benefits.
Blood vessel inflammation
Armlupeg (pegfilgrastim) can rarely cause serious inflammation of large or medium-sized blood vessels. This can happen as early as the first week of treatment. Contact your oncology care team right away if you develop an unexplained fever, stomach or back pain, headache, neck pain, or feel unusually unwell.
Armlupeg (pegfilgrastim) dosage
The average cost for 5 syringes of 0.6ml of 6mg/0.6ml of Armlupeg (pegfilgrastim) is $29,272.33 with a free GoodRx coupon.
Armlupeg (pegfilgrastim) is given as an injection under the skin using a prefilled syringe.
Lower risk the risk of infection during chemotherapy
Adults and children weighing 45 kg (99 lbs) or more
The typical dose is 6 mg once per chemotherapy cycle.
It shouldn't be given within 14 days before or 24 hours after chemotherapy.
After high-dose radiation exposure
Adults and children weighing 45 kg (99 lbs) or more
The typical dose is 6 mg as soon as possible after radiation exposure, followed by another 6 mg dose one week later.
Interactions between Armlupeg (pegfilgrastim) and other drugs
Armlupeg (pegfilgrastim) may interact with certain medications or supplements. Always let your doctor and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking. The list below does not include all possible drug interactions with Armlupeg (pegfilgrastim). Please note that only the generic name of each medication is listed below.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
How much does Armlupeg (pegfilgrastim) cost?
To access savings, use a GoodRx coupon and pay just a fraction of the retail price.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Armlupeg (pegfilgrastim) will not be safe for you to take.
GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.
Prescription savings
Stop paying too much for your prescriptions. Compare prices, get pharmacy coupons, and save up to 80%.
Armlupeg should be given at least 24 hours after chemotherapy and not within 14 days before your next chemotherapy treatment. It's typically given as a single injection once per chemotherapy cycle to help your body make more white blood cells and lower your risk of infection. After exposure to radiation that damages the bone marrow, Armlupeg is given as 2 injections, 1 week apart. Your care team will tell you when to receive each dose.
Armlupeg usually stays in your system for about 1 to 2 weeks after your injection, but this varies based on your white blood cell count. Its half-life, or how long it takes for half of the medication to leave your body, ranges from about 15 to 80 hours. As your white blood cell levels recover, your body clears the medication faster. Your care team will check your blood counts to see how well the treatment is working.
Yes, Armlupeg is a long-acting medication. Because it stays in your body much longer than short-acting treatments like Neupogen (filgrastim), you only need one injection per chemotherapy cycle instead of daily shots for several days.
Armlupeg isn't exactly the same as Neulasta (pegfilgrastim), but it's a biosimilar. This means it's highly similar to Neulasta and works the same way in your body. Both contain pegfilgrastim and have the same side effects. One difference is that Armlupeg is only recommended for children who weigh at least 45 kg (99 lbs), while Neulasta can also be given to children who weigh less. Talk to your prescriber if you have questions about how they compare.